Supernus Pharmaceuticals Inc.

SUPN | NASDAQ

Price Alert Chart Builder DCF Calculator

$43.63

+$0.85 (+1.99%)

Sep 22, 2026, 10:39 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	219.06M	207.71M	211.57M	192.1M	165.45M	149.82M	174.16M	175.69M	168.33M	143.64M	164.31M	153.88M	135.56M	153.76M	167.33M	177.35M	170.05M	152.51M	159.05M	148.46M	141.33M	130.93M
Cost of Revenue	33.67M	23.39M	23.01M	18.97M	16.83M	15.76M	26.1M	17.58M	17.92M	16.31M	19.63M	19.6M	21.09M	23.46M	22.95M	25.88M	20.46M	17.93M	16.99M	18.09M	25.03M	14.95M
Gross Profit	185.39M	184.31M	188.57M	173.14M	148.63M	134.06M	148.06M	158.11M	150.41M	127.34M	144.69M	134.28M	114.47M	130.3M	144.37M	151.48M	149.59M	134.57M	142.06M	130.38M	116.3M	115.98M
Operating Income	-57.96M	-7.44M	13.82M	-60.23M	12.14M	-10.26M	21.41M	40.85M	22.57M	-3.15M	-996K	8.14M	-17.59M	5.18M	34.33M	-1.52M	11.35M	1.97M	6.1M	32.6M	34.11M	13.21M
Interest Income	2.63M	2.38M	2.02M	2.28M	4.53M	4.43M	4.98M	4.1M	3.73M	3.4M	1.99M	1.75M	1.37M	5.35M	2.4M	2.8M	1.79M	14.7M	1.89M	2.28M	2.59M	3.81M
Pretax Income	-57.65M	-5.95M	-1.91M	-57.95M	16.67M	-5.83M	26.38M	44.94M	26.3M	243K	990K	9.89M	-17.13M	9.02M	35.14M	-444K	11.32M	14.72M	2.05M	28.96M	31.24M	10.93M
Net Income	-58.37M	-2.29M	-4.11M	-45.12M	22.5M	-11.83M	15.33M	38.5M	19.92M	124K	1.18M	-15.98M	-831K	16.95M	25.48M	1.75M	7.87M	25.62M	2.44M	21.56M	23.73M	5.69M
Selling & General & Admin	133.64M	125.17M	122.39M	179.68M	93.55M	89.94M	79.41M	69.75M	85.9M	86.52M	81.28M	82.7M	86.78M	85.6M	73.97M	112.31M	100.48M	90.46M	101.74M	72.03M	69.54M	61.46M
Research & Development	29.46M	39.44M	27.83M	29.37M	22.12M	26.93M	28.65M	29.04M	26.18M	24.93M	23.35M	22.66M	24.38M	21.21M	17.77M	19.55M	16.39M	20.84M	21.08M	19.65M	15.46M	34.28M
Other Expenses	80.25M	28.04M	24.53M	24.33M	20.82M	27.45M	18.6M	18.47M	15.75M	19.04M	41.05M	20.79M	20.9M	18.32M	18.29M	21.13M	21.39M	21.31M	13.15M	6.09M	-2.8M	7.03M
Operating Expenses	243.35M	192.65M	174.74M	233.37M	136.49M	144.32M	126.66M	117.26M	127.84M	130.49M	145.68M	126.14M	132.06M	125.13M	110.04M	153M	138.25M	132.61M	135.96M	97.78M	82.19M	102.76M
Interest Expense	2.32M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	910K	1.51M	1.59M	1.72M	1.81M	1.94M	5.93M	5.93M	5.47M	6.1M
Selling & Marketing Expenses	92.79M	n/a	83.19M	77.06M	65.13M	63.28M	54.59M	54.33M	58.8M	59.57M	55.28M	56.79M	59.89M	57.23M	47.99M	85.7M	73.58M	60.51M	62.18M	50.7M	48.38M	38.45M
Cost & Expenses	277.02M	215.15M	197.75M	252.33M	153.31M	160.08M	152.75M	134.84M	145.76M	146.8M	165.31M	145.74M	153.15M	148.59M	132.99M	178.88M	158.71M	150.54M	152.95M	115.86M	107.22M	117.72M
Income Tax Expense	723K	-3.66M	2.19M	-12.84M	-5.83M	6M	11.05M	6.45M	6.39M	119K	-185K	25.87M	-16.3M	-7.93M	9.66M	-2.19M	3.46M	-10.89M	-391K	7.4M	7.51M	5.24M
Shares Outstanding (Basic)	58.07M	57.65M	57.34M	56.4M	56.02M	55.86M	55.47M	55.15M	54.98M	54.8M	54.57M	54.61M	54.5M	54.38M	54.1M	53.79M	53.43M	53.33M	53.24M	53.19M	53.01M	52.93M
Shares Outstanding (Diluted)	58.07M	57.65M	57.34M	56.55M	56.64M	55.86M	56.46M	56.02M	55.72M	55.63M	55.06M	54.61M	54.5M	62.45M	62.09M	55.03M	61.4M	61.41M	54.53M	54.33M	54.72M	54.2M
EPS (Basic)	-1.01	-0.04	-0.07	-0.80	0.40	-0.21	0.28	0.70	0.36	0	0.02	-0.29	-0.02	0.31	0.47	0.03	0.15	0.48	0.05	0.41	0.45	0.11
EPS (Diluted)	-1.01	-0.04	-0.07	-0.80	0.40	-0.21	0.27	0.69	0.36	0	0.02	-0.29	-0.02	0.29	0.43	0.03	0.14	0.43	0.04	0.40	0.43	0.11
EBITDA	-29.59M	20.19M	26.67M	-33.15M	38.03M	17.79M	45.23M	65.05M	38.93M	16.5M	22.67M	31.75M	4.51M	31.12M	57.58M	23.06M	34.69M	38.03M	20.69M	41.56M	43.32M	23.62M
EBIT	-55.33M	-5.95M	1.66M	-57.95M	16.67M	-2.6M	26.38M	44.94M	18.21M	-4.25M	990K	9.89M	-16.22M	10.52M	36.73M	1.28M	13.13M	16.67M	7.99M	34.89M	36.7M	17.03M
Depreciation & Amortization	25.75M	26.14M	25.02M	24.81M	21.36M	20.38M	18.85M	20.1M	20.72M	20.75M	21.68M	21.86M	20.73M	20.6M	20.85M	21.78M	21.56M	21.36M	12.71M	6.68M	6.62M	6.59M